Leverage has crept up to a D/E of 0.81 as equity fell to $12.6B, with goodwill of $14.0B (45% of assets) posing an impairment overhang.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 |
|---|
| Total Current Assets | 7.69B | 7.9B | 7.92B | 8.7B | 8.2B | 7.97B | 7.28B | 7.17B | 7.85B | 6.37B | 6.88B | 6.19B | 5.52B | 4.55B | 4.63B | 4.39B | 3.87B | 3.3B | 3.03B | 2.65B | 2.59B | 2.08B | 1.8B | 1.75B | 1.74B | 2B | 1.68B | 1.53B | 1.21B |
| Cash & Short-Term Investments | 1.45B | 1.6B | 1.34B | 1.56B | 1.46B | 1.64B | 1.26B | 1.16B | 2.27B | 993.57M | 974.72M | 770.42M | 678.57M | 530.94M | 520.25M | 352.82M | 393.15M | 210.24M | 159.17M | 167.83M | 120.48M | 71.83M | 43.5M | 38.45M | 61.75M | 69.2M | 68.76M | 34.54M | 27.2M |
| Cash Only | 1.06B | 1.6B | 1.18B | 1.4B | 1.27B | 1.48B | 1.08B | 1.01B | 2.15B | 978.11M | 708.88M | 505.95M | 523.66M | 495.8M | 520.25M | 352.82M | 393.15M | 210.24M | 159.17M | 167.83M | 120.48M | 71.83M | 43.5M | 38.45M | 61.75M | 69.2M | 68.76M | 34.54M | 27.2M |
| Short-Term Investments | 388.1M | 0 | 163.09M | 154.37M | 187.83M | 159.18M | 179.26M | 155.55M | 119.51M | 15.46M | 265.84M | 264.47M | 154.91M | 35.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3.47B | 3.14B | 3.41B | 3.64B | 3.72B | 3.58B | 3.26B | 3.59B | 3.43B | 3.5B | 3.7B | 3.33B | 2.92B | 2.41B | 2.67B | 2.56B | 2.02B | 1.79B | 1.69B | 1.46B | 1.51B | 1.27B | 1.12B | 1.02B | 910.69M | 1.04B | 857.09M | 766.04M | 544.17M |
| Days Sales Outstanding | 63.87 | 58.43 | 64.35 | 68.26 | 69.99 | 74.17 | 66.7 | 75.02 | 75.67 | 71.85 | 79.31 | 79.31 | 81.86 | 83.19 | 93.49 | 94.52 | 81.37 | 83.04 | 80.89 | 79.85 | 85.55 | 81.06 | 88.77 | 84.52 | 68.61 | 69.24 | 69.93 | 73.26 | 66.45 |
| Inventory | 2.33B | 2.14B | 2.07B | 2.18B | 2.3B | 2.04B | 1.9B | 1.66B | 1.47B | 1.29B | 1.34B | 1.23B | 921.61M | 796.66M | 783.97M | 746.47M | 608.36M | 573.48M | 507.9M | 436.37M | 396.98M | 363.81M | 326.73M | 353.14M | 354.72M | 389.31M | 340.97M | 299.43M | 253.58M |
| Days Inventory Outstanding | 56.52 | 53.53 | 51.77 | 54.75 | 57.78 | 57.91 | 56.14 | 50.25 | 47 | 39.99 | 42.32 | 43.19 | 37.75 | 40.68 | 41.14 | 42.68 | 37.34 | 40.44 | 36.95 | 36.49 | 34.02 | 35.43 | 39.03 | 43.89 | 39.63 | 39.26 | 42.74 | 51.38 | 56.34 |
| Other Current Assets | 442.88M | 1.02B | 1.06B | 1.28B | 682.6M | 672.58M | 817.6M | 700.46M | 603.63M | 516.11M | 800.16M | 832.98M | 968.72M | 781.73M | 560.76M | 618.03M | 263.29M | 221.13M | 232.83M | 244.46M | 222.06M | 151.61M | 136.75M | 142.64M | 180.95M | 255.37M | 188.56M | 431.62M | 389.32M |
| Total Non-Current Assets | 23.6B | 23.1B | 25.64B | 25.23B | 27.55B | 26.4B | 24.41B | 25.77B | 18.4B | 17.65B | 18.62B | 17.01B | 15.35B | 12.19B | 12.25B | 10.68B | 8.98B | 7.74B | 7.69B | 7.07B | 7.3B | 4.66B | 4.07B | 4.21B | 4.73B | 5.32B | 4.68B | 4.19B | 3.63B |
| Property, Plant & Equipment | 6.43B | 3.01B | 7.26B | 7.45B | 8.34B | 8.55B | 8.19B | 8.52B | 3.84B | 3.49B | 3.58B | 3.15B | 2.72B | 2.25B | 2.22B | 2.03B | 1.9B | 1.69B | 1.61B | 1.41B | 1.31B | 1.03B | 871.88M | 864.81M | 874.7M | 942.49M | 786.83M | 638.13M | 538.45M |
| Fixed Asset Turnover | 3.49x | 6.51x | 2.66x | 2.61x | 2.33x | 2.06x | 2.18x | 2.05x | 4.31x | 5.09x | 4.76x | 4.85x | 4.79x | 4.71x | 4.69x | 4.87x | 4.77x | 4.65x | 4.75x | 4.73x | 4.93x | 5.57x | 5.27x | 5.08x | 5.54x | 5.79x | 5.69x | 5.98x | 5.55x |
| Goodwill | 13.97B | 0 | 15.17B | 14.65B | 15.79B | 14.36B | 12.96B | 14.02B | 12.21B | 12.1B | 12.99B | 11.92B | 10.76B | 8.44B | 8.64B | 7.09B | 6.12B | 5.24B | 5.25B | 4.97B | 5.22B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.28B | 14.83B | 1.37B | 1.36B | 1.52B | 1.46B | 1.38B | 1.43B | 681.33M | 683.06M | 805.55M | 759.62M | 714.97M | 548.84M | 536.95M | 529.79M | 520.72M | 599.68M | 608.07M | 473.22M | 501.11M | 3.41B | 2.99B | 3.07B | 3.57B | 4.14B | 3.7B | 3.42B | 2.97B |
| Long-Term Investments | 3.44B | 0 | 1.12B | 1.08B | 1.2B | 786.9M | 761.11M | 696.87M | 649.78M | 647.01M | 598.15M | 593.62M | 559.16M | 482.49M | 481.94M | 533.93M | 188.26M | 4.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 296.47M | 5.26B | 720.02M | 681.83M | 702.46M | 1.24B | 1.13B | 1.11B | 1.02B | 725.15M | 683.12M | 610.72M | 614.8M | 479.79M | 302.01M | 427.94M | 179.12M | 162.47M | 159.75M | 163.13M | 222.86M | 192.66M | 168.43M | 239.84M | 249.36M | 203.52M | 166.41M | 129.49M | 119.3M |
| Total Assets | 31.29B | 31B | 33.57B | 33.93B | 35.75B | 34.37B | 31.69B | 32.93B | 26.24B | 24.03B | 25.5B | 23.2B | 20.87B | 16.74B | 16.88B | 15.07B | 12.85B | 11.04B | 10.72B | 9.72B | 9.88B | 6.74B | 5.87B | 5.96B | 6.46B | 7.32B | 6.37B | 5.72B | 4.84B |
| Asset Turnover | 0.62x | 0.63x | 0.58x | 0.57x | 0.54x | 0.51x | 0.56x | 0.53x | 0.63x | 0.74x | 0.67x | 0.66x | 0.62x | 0.63x | 0.62x | 0.66x | 0.71x | 0.71x | 0.71x | 0.69x | 0.65x | 0.85x | 0.78x | 0.74x | 0.75x | 0.75x | 0.70x | 0.67x | 0.62x |
| Asset Growth % | -16.5% | -7.64% | -1.07% | -5.1% | 4.04% | 8.45% | -3.78% | 25.5% | 9.23% | -5.8% | 9.93% | 11.15% | 24.66% | -0.82% | 12.02% | 17.25% | 16.4% | 3.03% | 10.27% | -1.67% | 46.64% | 14.76% | -1.42% | -7.79% | -11.77% | 15.04% | 11.36% | 18.05% | - |
| Total Current Liabilities | 7.18B | 6.25B | 5.66B | 6.11B | 6.47B | 7.26B | 6.06B | 7.06B | 6.27B | 5.3B | 5.3B | 3.8B | 2.86B | 2.57B | 2.4B | 3.29B | 2.85B | 1.82B | 2.26B | 2.08B | 1.8B | 1.33B | 1.43B | 1.12B | 1.23B | 1.55B | 1.48B | 1.76B | 831.86M |
| Accounts Payable | 891.84M | 738M | 984.32M | 885.15M | 951.58M | 857.53M | 827.39M | 835.19M | 795.05M | 737.84M | 839.63M | 714.21M | 587.1M | 482.68M | 563.81M | 503.55M | 316.28M | 252.95M | 262.92M | 226.28M | 418.86M | 261.11M | 225.73M | 243.39M | 177.2M | 222.86M | 299.4M | 280.82M | 127.47M |
| Days Payables Outstanding | 21.35 | 18.45 | 24.64 | 22.24 | 23.95 | 24.37 | 24.51 | 25.23 | 25.47 | 22.86 | 26.57 | 24.99 | 24.05 | 24.65 | 29.59 | 28.79 | 19.41 | 17.84 | 19.13 | 18.92 | 35.89 | 25.43 | 26.96 | 30.25 | 19.8 | 22.48 | 37.53 | 48.19 | 28.32 |
| Short-Term Debt | 1.74B | 1.61B | 577.38M | 944.6M | 1.34B | 1.92B | 1.09B | 2.62B | 2.5B | 1.65B | 1.3B | 725M | 371.26M | 484.77M | 345.23M | 1.32B | 710.05M | 338.1M | 818.62M | 208.92M | 375.77M | 250.03M | 483.25M | 166.57M | 146.15M | 307.25M | 616.57M | 570.3M | 183.15M |
| Deferred Revenue (Current) | 0 | 0 | 82.17M | 85.82M | 105.72M | 518.03M | 606.3M | 30.94M | 0 | 275.13M | 218.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 249.3M | 0 | 0 | 0 |
| Other Current Liabilities | 3.73B | 3.31B | 2.84B | 2.99B | 2.86B | 2.75B | 2.42B | 2.44B | 2.9B | 2.48B | 1.98B | 765.91M | 793.54M | 700.59M | 642.25M | 716.96M | 873.33M | 22.98M | 20.58M | 474.88M | 100.03M | 113.2M | 173.86M | 162.13M | 281.8M | 308.74M | 147.51M | 908.08M | 521.23M |
| Current Ratio | 1.07x | 1.26x | 1.40x | 1.42x | 1.27x | 1.10x | 1.20x | 1.02x | 1.25x | 1.20x | 1.30x | 1.63x | 1.93x | 1.77x | 1.93x | 1.34x | 1.36x | 1.81x | 1.34x | 1.28x | 1.44x | 1.56x | 1.26x | 1.56x | 1.41x | 1.29x | 1.14x | 0.87x | 1.46x |
| Quick Ratio | 0.75x | 0.92x | 1.03x | 1.07x | 0.91x | 0.82x | 0.89x | 0.78x | 1.02x | 0.96x | 1.05x | 1.31x | 1.61x | 1.46x | 1.61x | 1.11x | 1.15x | 1.50x | 1.11x | 1.07x | 1.22x | 1.29x | 1.03x | 1.25x | 1.12x | 1.04x | 0.91x | 0.70x | 1.15x |
| Cash Conversion Cycle | 99.04 | 93.51 | 91.48 | 100.77 | 103.83 | 107.72 | 98.34 | 100.04 | 97.19 | 88.99 | 95.06 | 97.51 | 95.56 | 99.22 | 105.04 | 108.41 | 99.3 | 105.64 | 98.71 | 97.42 | 83.68 | 91.06 | 100.83 | 98.16 | 88.44 | 86.03 | 75.14 | 76.45 | 94.47 |
| Total Non-Current Liabilities | 10.58B | 10.47B | 12.14B | 12.99B | 13.84B | 13.13B | 13.3B | 12.65B | 7.07B | 7.9B | 9.15B | 9.8B | 9.77B | 7.3B | 7.52B | 5.56B | 4.35B | 4.48B | 4.06B | 3.82B | 4.34B | 2.04B | 1.75B | 2.25B | 2.53B | 2.81B | 2.01B | 1.95B | 1.98B |
| Long-Term Debt | 5.82B | 5.69B | 6.26B | 6.96B | 7.17B | 6.65B | 6.8B | 6.46B | 5.05B | 5.79B | 6.83B | 7.18B | 7.41B | 5.61B | 5.93B | 4.24B | 3.24B | 3.09B | 2.84B | 2.75B | 2.9B | 597.01M | 402.46M | 882.66M | 1.04B | 826.94M | 700.42M | 649.72M | 921.81M |
| Capital Lease Obligations | 11.63B | 2.91B | 3.5B | 3.53B | 4B | 4.09B | 3.88B | 4.07B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 2.04B | 0 | 708.89M | 750.29M | 936.48M | 868.45M | 785.89M | 739.7M | 626.52M | 467.54M | 661.92M | 571.21M | 661.68M | 538.35M | 502.08M | 453.52M | 381.14M | 298.4M | 306.23M | 259.6M | 286.78M | 253.85M | 208.22M | 198.86M | 161.41M | 160.55M | 187.91M | 166.99M | 162.01M |
| Other Non-Current Liabilities | 1.27B | 1.88B | 1.63B | 1.74B | 1.72B | 1.53B | 1.83B | 1.38B | 1.4B | 1.63B | 1.66B | 2.05B | 1.69B | 1.15B | 1.09B | 869.24M | 725.17M | 1.09B | 911.43M | 813.47M | 1.15B | 1.19B | 1.14B | 1.17B | 1.33B | 1.82B | 1.12B | 1.13B | 900.25M |
| Total Liabilities | 17.76B | 16.72B | 17.8B | 19.1B | 20.3B | 20.39B | 19.36B | 19.71B | 13.34B | 13.2B | 14.45B | 13.6B | 12.63B | 9.87B | 9.92B | 8.85B | 7.2B | 6.3B | 6.32B | 5.9B | 6.14B | 3.37B | 3.18B | 3.37B | 3.76B | 4.36B | 3.49B | 3.71B | 2.82B |
| Total Debt | 10.96B | 10.79B | 11B | 12.08B | 13.21B | 13.32B | 12.38B | 13.82B | 7.58B | 7.52B | 8.13B | 7.96B | 7.82B | 6.12B | 6.27B | 5.56B | 3.95B | 3.43B | 3.66B | 2.96B | 3.28B | 847.04M | 885.71M | 1.05B | 1.18B | 1.13B | 1.32B | 1.22B | 1.1B |
| Net Debt | 9.9B | 9.2B | 9.82B | 10.67B | 11.94B | 11.84B | 11.3B | 12.81B | 5.43B | 6.55B | 7.42B | 7.46B | 7.3B | 5.62B | 5.75B | 5.21B | 3.56B | 3.22B | 3.5B | 2.79B | 3.16B | 775.21M | 842.21M | 1.01B | 1.12B | 1.06B | 1.25B | 1.19B | 1.08B |
| Debt / Equity | 0.81x | 0.76x | 0.70x | 0.81x | 0.86x | 0.95x | 1.00x | 1.04x | 0.59x | 0.69x | 0.74x | 0.83x | 0.95x | 0.89x | 0.90x | 0.89x | 0.70x | 0.72x | 0.83x | 0.77x | 0.87x | 0.25x | 0.33x | 0.41x | 0.44x | 0.38x | 0.46x | 0.61x | 0.55x |
| Debt / EBITDA | 3.18x | 3.24x | 3.43x | 3.87x | 3.94x | 3.83x | 3.03x | 3.58x | 2.01x | 2.43x | 2.53x | 2.86x | 3.22x | 2.91x | 2.94x | 2.74x | 2.16x | 2.22x | 2.44x | 2.22x | 2.66x | 0.84x | 1.11x | 1.36x | 1.37x | 1.44x | 1.35x | 1.45x | 1.69x |
| Net Debt / EBITDA | 2.88x | 2.76x | 3.06x | 3.42x | 3.56x | 3.41x | 2.76x | 3.32x | 1.44x | 2.11x | 2.31x | 2.68x | 3.01x | 2.67x | 2.70x | 2.56x | 1.95x | 2.08x | 2.33x | 2.09x | 2.56x | 0.77x | 1.05x | 1.31x | 1.30x | 1.35x | 1.28x | 1.41x | 1.65x |
| Interest Coverage | 4.88x | 4.93x | 3.60x | 3.43x | 4.39x | 5.45x | 5.72x | 4.75x | 4.87x | 5.80x | 5.79x | 4.88x | 4.72x | 5.13x | 5.11x | 5.99x | 6.38x | 5.53x | 4.69x | 4.03x | 3.60x | - | - | - | - | - | - | - | - |
| Total Equity | 13.53B | 14.28B | 15.77B | 14.83B | 15.45B | 13.98B | 12.33B | 13.23B | 12.9B | 10.83B | 11.05B | 9.6B | 8.25B | 6.87B | 6.96B | 6.22B | 5.66B | 4.75B | 4.4B | 3.82B | 3.75B | 3.37B | 2.69B | 2.59B | 2.7B | 2.96B | 2.87B | 2.01B | 2.03B |
| Equity Growth % | -29.32% | -9.42% | 6.35% | -4.03% | 10.52% | 13.36% | -6.77% | 2.52% | 19.15% | -2.02% | 15.11% | 16.41% | 20.06% | -1.34% | 11.94% | 9.94% | 19.22% | 7.88% | 15.02% | 2.05% | 11.28% | 24.96% | 4.17% | -4.07% | -9.01% | 3.09% | 42.92% | -0.75% | - |
| Book Value per Share | 25.09 | 24.53 | 26.87 | 25.27 | 13.17 | 11.93 | 13.90 | 14.91 | 21.00 | 17.62 | 18.04 | 15.72 | 13.61 | 11.28 | 11.34 | 10.19 | 9.37 | 7.95 | 7.38 | 6.44 | 6.33 | 5.72 | 4.18 | 6.16 | 6.42 | 7.06 | 5.33 | 4.25 | 4.83 |
| Total Shareholders' Equity | 12.56B | 14.28B | 14.58B | 13.62B | 13.99B | 12.7B | 11.22B | 11.96B | 11.76B | 9.82B | 9.98B | 9.04B | 7.77B | 6.69B | 6.76B | 6.1B | 5.55B | 4.66B | 4.28B | 3.82B | 3.69B | 3.36B | 2.68B | 2.58B | 2.68B | 2.94B | 2.85B | 1.99B | 2.01B |
| Common Stock | 268.56M | 14.28B | 293.41M | 293.41M | 293.41M | 293M | 292.88M | 304.44M | 307.88M | 308.11M | 360.92M | 354.12M | 316.79M | 276.93M | 283.49M | 0 | 0 | 145.92M | 0 | 0 | 229.29M | 193.76M | 169.29M | 182.23M | 218.7M | 257.93M | 244.35M | 228.07M | 195.43M |
| Retained Earnings | 12.09B | 0 | 11.27B | 10.92B | 10.71B | 10.83B | 10.25B | 9.45B | 8.83B | 7.14B | 8.4B | 7.2B | 5.84B | 4.62B | 4.21B | 3.59B | 2.9B | 2.17B | 1.76B | 1.29B | 1.03B | 823.52M | 485.32M | 300.15M | 147.32M | -65.69M | -59.65M | -215.52M | 68.3M |
| Treasury Stock | -93.79M | 0 | 0 | 0 | 0 | 0 | 0 | -370.5M | -50.99M | -108.93M | -50.99M | -464.99M | -417.22M | -366.72M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.31B | 0 | -328.55M | -975.17M | -388.47M | -1.31B | -2.21B | -1.04B | -1.2B | -1.49B | -1.25B | -1.22B | -894.52M | -398.72M | -372.11M | -374.79M | -145.9M | -34.71M | -108.67M | 69.19M | -4.1M | -120.55M | -50.85M | -138.8M | -365.33M | -403.57M | -205.46M | -134.57M | -64.8M |
| Minority Interest | 974.54M | 0 | 1.19B | 1.21B | 1.46B | 1.28B | 1.12B | 1.27B | 1.14B | 1.01B | 616.47M | 556.9M | 481.13M | 181.38M | 200.19M | 316.34M | 110.27M | 145.71M | 0 | 72.57M | 56.95M | 12.16M | 13.3M | 11.2M | 21.46M | 22.74M | 22.65M | 21.64M | 16.97M |
Labor cost inflation
Total assets contracted from $34.3B in 2024Q1 to $31.3B in 2026Q2, while debt fell from $12.1B to $11.0B, per reported figures, indicating a gradual deleveraging trend.
The balance sheet has been shrinking over the past two years, with total assets down roughly 9% from the 2024Q1 peak. This contraction appears driven by asset disposals and a reduction in goodwill, which fell from $14.7B to $14.0B, suggesting portfolio pruning. The modest decline in total debt alongside stable equity levels implies a deliberate effort to reduce leverage, though the pace is slow and may reflect limited growth opportunities.
Debt-to-equity rose from 0.70 in 2025Q1 to 0.81 in 2026Q2, per financial statements, as equity eroded by $1.8B while total debt remained near $11B.
The D/E ratio has increased from 0.70 to 0.81 over the last five quarters, not because of additional borrowing but because equity has declined. Retained earnings have been volatile, dropping to zero in 2025Q4 before recovering to $12.1B, suggesting dividend payouts or impairments. The absolute debt level is stable, but the rising leverage ratio indicates a thinner equity cushion, which could amplify sensitivity to interest rate changes.
Goodwill of $14.0B represents 45% of total assets as of 2026Q2, per balance sheet data, while net PPE is only $6.4B, underscoring the acquisition-heavy growth model.
The asset mix is heavily weighted toward intangible assets, with goodwill nearly double the tangible fixed asset base. This suggests that past acquisitions have been the primary driver of scale, but it also exposes the balance sheet to impairment risk if cash flows from those acquisitions underperform. The relatively low PPE relative to revenue indicates an asset-light service model, but the high goodwill raises questions about the quality of capital deployed.
Total equity fell from $14.6B in 2024Q4 to $12.6B in 2026Q2, per reported figures, while share repurchases totaled $1.06B over the last four quarters, per cash flow statements.
The decline in equity is notable, with a $2B reduction over six quarters, even as the company returned over $1B to shareholders via buybacks. Retained earnings have been inconsistent, dropping to zero in 2025Q4, which may indicate a large dividend or a reclassification. The combination of buybacks and shrinking equity suggests that capital returns are not being fully offset by earnings retention, potentially straining the equity base.
Current ratio fell from 1.50 in 2024Q1 to 1.07 in 2026Q2, per balance sheet data, while cash declined from $1.1B to $1.1B, indicating a tighter short-term position.
The current ratio has deteriorated steadily, from 1.50 to 1.07, approaching the 1.0 threshold that signals potential liquidity stress. Cash levels have remained flat around $1.1B, but current liabilities have grown relative to current assets, likely due to increased payables or accrued expenses. This trend warrants monitoring, as a ratio below 1.0 could indicate difficulty meeting short-term obligations without external financing.
Goodwill of $14.0B, per balance sheet, is nearly 45% of total assets, and any impairment would directly hit equity, which is already under pressure.
The large goodwill balance is the most significant distortion on the balance sheet. Given the company's strained profitability and modest growth, the carrying value of these intangibles may not be fully supported by future cash flows. An impairment charge would reduce equity further and could push the D/E ratio higher, compounding the leverage concerns. Investors should monitor segment performance and any indicators of impairment testing.
Quick answers to the most common questions about buying FMS stock.
As of 2025, Fresenius Medical Care AG & Co. KGaA (FMS) had total assets of $31.00B including $7.90B in current assets.
Fresenius Medical Care AG & Co. KGaA (FMS) carries total debt of $10.79B, offset by $1.60B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Fresenius Medical Care AG & Co. KGaA (FMS) has total shareholders' equity (book value) of $14.28B ($24.53 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Fresenius Medical Care AG & Co. KGaA (FMS) reported a current ratio of 1.26x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.